Works matching IS 10837159 AND DT 2017 AND VI 22 AND IP 4
Results: 22
Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 386, doi. 10.1634/theoncologist.2016-0369
- By:
- Publication type:
- Article
Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 438, doi. 10.1634/theoncologist.2016-0192
- By:
- Publication type:
- Article
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 377, doi. 10.1634/theoncologist.2016-0257
- By:
- Publication type:
- Article
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 480, doi. 10.1634/theoncologist.2016-0354
- By:
- Publication type:
- Article
Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 450, doi. 10.1634/theoncologist.2016-0444
- By:
- Publication type:
- Article
Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 487, doi. 10.1634/theoncologist.2016-0352
- By:
- Publication type:
- Article
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 402, doi. 10.1634/theoncologist.2016-0241
- By:
- Publication type:
- Article
On the Interpretation of the Hazard Ratio and Communication of Survival Benefit.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 484, doi. 10.1634/theoncologist.2016-0198
- By:
- Publication type:
- Article
Using Metaphors to Explain Molecular Testing to Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 445, doi. 10.1634/theoncologist.2016-0270
- By:
- Publication type:
- Article
Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 409, doi. 10.1634/theoncologist.2016-0351
- By:
- Publication type:
- Article
Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 422, doi. 10.1634/theoncologist.2016-0289
- By:
- Publication type:
- Article
Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 470, doi. 10.1634/theoncologist.2016-0419
- By:
- Publication type:
- Article
In Memoriam: Umberto Veronesi (1925-2016).
- Published in:
- 2017
- By:
- Publication type:
- Obituary
Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 460, doi. 10.1634/theoncologist.2016-0283
- By:
- Publication type:
- Article
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133
- By:
- Publication type:
- Article
Academic Cancer Center Phase I Program Development.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 369, doi. 10.1634/theoncologist.2016-0409
- By:
- Publication type:
- Article
Diazoxide for Lowering Insulin Levels in Breast Cancer Patients.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 416, doi. 10.1634/theoncologist.2016-0310
- By:
- Publication type:
- Article
End-of-Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 361, doi. 10.1634/theoncologist.2016-0277
- By:
- Publication type:
- Article
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 379, doi. 10.1634/theoncologist.2016-0211
- By:
- Publication type:
- Article
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 394, doi. 10.1634/theoncologist.2016-0307
- By:
- Publication type:
- Article
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 432, doi. 10.1634/theoncologist.2016-0254
- By:
- Publication type:
- Article